The obesity paradox in multiple myeloma: A report from Multiple Myeloma Research Foundation (MMRF) dataset

Abstract Background Obesity is a risk factor for multiple myeloma (MM). However, we still lack knowledge on the clinical course of obese MM patients in a broad view. Methods Here, we reviewed 568 MM patients recorded in the Multiple Myeloma Research Foundation (MMRF) coMMpass dataset. Patients were...

Full description

Bibliographic Details
Main Authors: Liang Ren, Tianhong Xu, Yuhong Ren, Peng Liu
Format: Article
Language:English
Published: Wiley 2023-12-01
Series:Cancer Medicine
Subjects:
Online Access:https://doi.org/10.1002/cam4.6685
_version_ 1797387126581493760
author Liang Ren
Tianhong Xu
Yuhong Ren
Peng Liu
author_facet Liang Ren
Tianhong Xu
Yuhong Ren
Peng Liu
author_sort Liang Ren
collection DOAJ
description Abstract Background Obesity is a risk factor for multiple myeloma (MM). However, we still lack knowledge on the clinical course of obese MM patients in a broad view. Methods Here, we reviewed 568 MM patients recorded in the Multiple Myeloma Research Foundation (MMRF) coMMpass dataset. Patients were divided into the normal and obese groups according body mass index (BMI) at diagnosis, and then the baseline characteristics, cytogenetic abnormalities, treatment variability, and survival outcomes were evaluated in the obese cohort. Results We found no differences in the characteristics when comparing normal and obese MM patients other than more male in the obese part (50.4% vs. 59.9%, p = 0.024). Compared with the normal BMI patients, median overall survival (OS) was shorter for obese MM patients but without significant meaning (82.3 vs. 95.3 months, p = 0.25). However, in the subgroup analysis, obese MM patients younger than 65 years had significantly inferior OS than that in the normal category (p = 0.047). We also found obese MM patients had a higher overall response rate (ORR) compared with normal BMI patients (92.7% vs. 88.6%, p = 0.037). Additionally, obese patients seemed to achieve faster best response during first‐line therapy. Conclusions Obesity assumes a paradoxical function in the clinical trajectory of myeloma.
first_indexed 2024-03-08T22:19:23Z
format Article
id doaj.art-83464b7edff442de9cb6209d08d17429
institution Directory Open Access Journal
issn 2045-7634
language English
last_indexed 2024-03-08T22:19:23Z
publishDate 2023-12-01
publisher Wiley
record_format Article
series Cancer Medicine
spelling doaj.art-83464b7edff442de9cb6209d08d174292023-12-18T14:43:07ZengWileyCancer Medicine2045-76342023-12-011223214002140710.1002/cam4.6685The obesity paradox in multiple myeloma: A report from Multiple Myeloma Research Foundation (MMRF) datasetLiang Ren0Tianhong Xu1Yuhong Ren2Peng Liu3Department of Hematology Zhongshan Hospital, Fudan University Shanghai P. R. ChinaDepartment of Hematology Zhongshan Hospital, Fudan University Shanghai P. R. ChinaDepartment of Hematology Zhongshan Hospital, Fudan University Shanghai P. R. ChinaDepartment of Hematology Zhongshan Hospital, Fudan University Shanghai P. R. ChinaAbstract Background Obesity is a risk factor for multiple myeloma (MM). However, we still lack knowledge on the clinical course of obese MM patients in a broad view. Methods Here, we reviewed 568 MM patients recorded in the Multiple Myeloma Research Foundation (MMRF) coMMpass dataset. Patients were divided into the normal and obese groups according body mass index (BMI) at diagnosis, and then the baseline characteristics, cytogenetic abnormalities, treatment variability, and survival outcomes were evaluated in the obese cohort. Results We found no differences in the characteristics when comparing normal and obese MM patients other than more male in the obese part (50.4% vs. 59.9%, p = 0.024). Compared with the normal BMI patients, median overall survival (OS) was shorter for obese MM patients but without significant meaning (82.3 vs. 95.3 months, p = 0.25). However, in the subgroup analysis, obese MM patients younger than 65 years had significantly inferior OS than that in the normal category (p = 0.047). We also found obese MM patients had a higher overall response rate (ORR) compared with normal BMI patients (92.7% vs. 88.6%, p = 0.037). Additionally, obese patients seemed to achieve faster best response during first‐line therapy. Conclusions Obesity assumes a paradoxical function in the clinical trajectory of myeloma.https://doi.org/10.1002/cam4.6685BMIcytogenetic abnormalmultiple myelomaobesity paradoxprognosis
spellingShingle Liang Ren
Tianhong Xu
Yuhong Ren
Peng Liu
The obesity paradox in multiple myeloma: A report from Multiple Myeloma Research Foundation (MMRF) dataset
Cancer Medicine
BMI
cytogenetic abnormal
multiple myeloma
obesity paradox
prognosis
title The obesity paradox in multiple myeloma: A report from Multiple Myeloma Research Foundation (MMRF) dataset
title_full The obesity paradox in multiple myeloma: A report from Multiple Myeloma Research Foundation (MMRF) dataset
title_fullStr The obesity paradox in multiple myeloma: A report from Multiple Myeloma Research Foundation (MMRF) dataset
title_full_unstemmed The obesity paradox in multiple myeloma: A report from Multiple Myeloma Research Foundation (MMRF) dataset
title_short The obesity paradox in multiple myeloma: A report from Multiple Myeloma Research Foundation (MMRF) dataset
title_sort obesity paradox in multiple myeloma a report from multiple myeloma research foundation mmrf dataset
topic BMI
cytogenetic abnormal
multiple myeloma
obesity paradox
prognosis
url https://doi.org/10.1002/cam4.6685
work_keys_str_mv AT liangren theobesityparadoxinmultiplemyelomaareportfrommultiplemyelomaresearchfoundationmmrfdataset
AT tianhongxu theobesityparadoxinmultiplemyelomaareportfrommultiplemyelomaresearchfoundationmmrfdataset
AT yuhongren theobesityparadoxinmultiplemyelomaareportfrommultiplemyelomaresearchfoundationmmrfdataset
AT pengliu theobesityparadoxinmultiplemyelomaareportfrommultiplemyelomaresearchfoundationmmrfdataset
AT liangren obesityparadoxinmultiplemyelomaareportfrommultiplemyelomaresearchfoundationmmrfdataset
AT tianhongxu obesityparadoxinmultiplemyelomaareportfrommultiplemyelomaresearchfoundationmmrfdataset
AT yuhongren obesityparadoxinmultiplemyelomaareportfrommultiplemyelomaresearchfoundationmmrfdataset
AT pengliu obesityparadoxinmultiplemyelomaareportfrommultiplemyelomaresearchfoundationmmrfdataset